AVECTOR
Avector is an innovative technology company that specializes in customized property systems in operation, maintenance and energy follow-up as well as consultancy services in inventory, planning and procurement in the real estate industry. Thanks to a long experience in the industry, our consultants and system developers are well acquainted with what real estate management is all about. We help our customers to increase their knowledge of their operations – for better control and increased pro... fitability. Our systems and services are developed in close collaboration with the business community and are thus optimized for your needs – real estate systems, energy monitoring systems and real estate consulting services. We have been developing web-based property management systems for facility management since the 21st century and were thus the first in Sweden. Over the years, we have built up a wide network of skilled partners in various areas. AB Volvo, Nolato, Bring, Nowaste Logistics and Continental Bakeries are examples of companies that employ us. Our goal is to continuously develop and improve our systems and services. Our key words are efficiency, flexibility and responsiveness.
AVECTOR
Industry:
Energy Software
Founded:
2002-07-03
Address:
Ängelholm, Kronobergs Lan, Sweden
Country:
Sweden
Website Url:
http://www.avector.com
Total Employee:
11+
Status:
Active
Contact:
+46431-40 25 90
Email Addresses:
[email protected]
Technology used in webpage:
LetsEncrypt Amazon Microsoft ASP.NET MVC Amazon Ireland Region Heroku DNS Swedish Server Location Lotame Crowd Control Yahoo Web Analytics Adobe Audience Manager Sync
Similar Organizations
Ecosolve GmbH
Ecosolve GmbH is an energy management company that specializes in complete systems in the field of environmental and energy technology.
Equinor
Equinor is an energy company that specializes in providing oil, gas, wind energy, and solar power energy.
Official Site Inspections
http://www.avector.com
- Host name: webfront3.webcluster.loopia.se
- IP address: 93.188.2.53
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Avector"
Our Executive Leadership & Board of Directors - Alector
Virginia joined Alector in 2018, leading the Portfolio and Program Management function. Prior to Alector, Virginia held various roles of increasing responsibility at Genentech from 2007 through …See details»
Alector turns to layoffs as Alzheimer’s drug fails
6 days ago In an emailed statement, a company spokesperson said the reductions were across the organization. As of Sept. 30, Alector had $457 million in cash, cash equivalents and investments, which the ...See details»
Alector Therapeutics for Neurodegenerative Disease
Breakthroughs come from unexpected places. At Alector, we know that discoveries can only come from boundless curiosity. We are driven to tap into that spirit of inquisitiveness and imagination …See details»
About Us - Alector
Alector is on a mission to develop therapies that improve healthy function to the brain. By unlocking the power of immunology, neuroscience, and human genetics, we’re trailblazing immuno-neurology—a visionary therapeutic approach to …See details»
Alector Corporate Overview
Alector is not aware of any other TREM-2 activating candidates in a Phase 2 or Phase 3 trial for AD as of November 2024. AL002 (TREM2 Activator): Promising Immuno-neurology Candidate …See details»
Alector - LinkedIn
At Alector, we’re working at the intersection of human genetics and neuroscience to harness the power of microglia in the brain’s immune system to counteract neurodegenerative diseases, like AD.See details»
Alector, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Alector is at the forefront of developing innovative therapeutics for Alzheimer's disease, dementia, and other neurodegenerative disorders by utilizing advanced antibody technology and …See details»
Alector - Funding, Financials, Valuation & Investors - Crunchbase
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel. Search Crunchbase. ... Which …See details»
Alector Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Alector has 5 employees at their 1 location and $97.06 m in annual revenue in FY 2023. See insights on Alector including office locations, competitors, revenue, financials, …See details»
Alector and AbbVie Announce Collaboration to Advance a Novel …
Alector will receive a $205 millionupfront payment and a potential, future equity investment of up to $20 million. Alector is a portfolio company of AbbVie Ventures. About Alector LLC Alector is …See details»
Avector - Crunchbase Company Profile & Funding
Avector is an innovative technology company that specializes in customized property systems in operation, maintenance and energy follow-up as well as consultancy services in inventory, …See details»
Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 …
Jul 28, 2024 Alector and AbbVie will share development costs and profits after marketing approval, though Alector may opt out of development cost sharing and instead receive …See details»
Alector: Bleak Prospects After Alzheimer's Failure
Alector's Phase 2 trial for AL002 in early Alzheimer's disease failed, causing a +30% stock drop and raising doubts about TREM2 as a viable target. The company has significant cash …See details»
Our History Overview - Alector
Achieved target enrollment with 103 symptomatic and 16 at-risk FTD-GRN participants in the pivotal, randomized, double-blind, placebo-controlled INFRONT-3 Phase 3 clinical trial of …See details»
With GSK, Alector has the Big Pharma backing to capitalize on a …
Jan 27, 2022 RELATED: GSK, under pressure to perform, pens $2.2B deal with Alector focused on neuro R&D, Alzheimer's He cited Bristol Myers Squibb, which paid Prothena $80 million to …See details»
Alector - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Alector . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 14. Number of Board …See details»
Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 …
Feb 8, 2024 SOUTH SAN FRANCISCO, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC) and GSK plc (LSE/NYSE: GSK) today announced that the first patient …See details»
Alector Announces Appointment of Sara Kenkare-Mitra, Ph.D., as ...
Dec 15, 2021 During her 23-year tenure, she led a large, integrated global organization of approximately 650 employees, and played a key role in the filing of more than 100 …See details»
Alector stock drops after Alzheimer’s drug fails in Phase II trial
6 days ago Alector’s internal pipeline suffered a blow as the Phase II INVOKE-2 trial evaluating its Alzheimer’s disease therapy, AL002, failed to meet the primary endpoint.. The therapy …See details»